Moxetumomab Pasudotox-tdfk and Verapamil Extended Release Capsules
Determining the interaction of Moxetumomab Pasudotox-tdfk and Verapamil Extended Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: verapamil
Brand name: Calan, Isoptin SR, Verelan, Isoptin, Calan SR, Isoptin IV, Covera-HS, Verelan PM
Synonyms: Verapamil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Verapamil Extended Release Tablets
- Moxetumomab Pasudotox-tdfk-Verapamil Hydrochloride
- Moxetumomab Pasudotox-tdfk-Verapamil Hydrochloride PM
- Moxetumomab Pasudotox-tdfk-Verapamil Immediate-Release Tablets
- Moxetumomab Pasudotox-tdfk-Verapamil Injection
- Moxetumomab Pasudotox-tdfk-Verapamil Intravenous
- Verapamil Extended Release Capsules-Moxetumomab pasudotox-tdfk Intravenous
- Verapamil Extended Release Capsules-Moxifloxacin
- Verapamil Extended Release Capsules-Moxifloxacin (Systemic)
- Verapamil Extended Release Capsules-Moxifloxacin Hydrochloride
- Verapamil Extended Release Capsules-Moxifloxacin Injection
- Verapamil Extended Release Capsules-Moxifloxacin Intravenous